Proteomics

Dataset Information

0

Multi-omic analysis of Esophageal Adenocarcinoma uncovers candidate therapeutic targets and cancer-selective post-transcriptional regulation


ABSTRACT: Efforts to address the poor prognosis associated with esophageal adenocarcinoma (EAC) have been hampered by a lack of biomarkers to identify early disease and therapeutic targets. Despite extensive efforts to understand the somatic mutations associated with EAC over the past decade, a gap remains in understanding how the atlas of genomic aberrations in this cancer impacts the proteome and which somatic variants are of importance for the disease phenotype. We performed a quantitative proteomic analysis of 23 EACs and matched adjacent normal esophageal and gastric tissues. We explored the correlation of transcript and protein abundance using tissue-matched RNAseq and proteomic data from 7 patients and further integrated these data with a cohort of EAC RNA-seq data (n=264 patients), EAC whole-genome sequencing (n=454 patients) and external published datasets.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Esophagus Squamous Epithelium, Esophagus

DISEASE(S): Gastroesophageal Adenocarcinoma

SUBMITTER: Javier Alfaro  

LAB HEAD: Javier Alfaro

PROVIDER: PXD042792 | Pride | 2024-08-10

REPOSITORIES: Pride

Dataset's files

Source:
altmetric image

Publications

Multi-Omic Analysis of Esophageal Adenocarcinoma Uncovers Candidate Therapeutic Targets and Cancer-Selective Posttranscriptional Regulation.

O'Neill J Robert JR   Yébenes Mayordomo Marcos M   Mitulović Goran G   Al Shboul Sofian S   Bedran Georges G   Faktor Jakub J   Hernychova Lenka L   Uhrik Lukas L   Gómez-Herranz Maria M   Kocikowski Mikołaj M   Save Vicki V   Vojtěšek Bořivoj B   Arends Mark J MJ   Hupp Ted T   Alfaro Javier Antonio JA  

Molecular & cellular proteomics : MCP 20240409 6


Efforts to address the poor prognosis associated with esophageal adenocarcinoma (EAC) have been hampered by a lack of biomarkers to identify early disease and therapeutic targets. Despite extensive efforts to understand the somatic mutations associated with EAC over the past decade, a gap remains in understanding how the atlas of genomic aberrations in this cancer impacts the proteome and which somatic variants are of importance for the disease phenotype. We performed a quantitative proteomic an  ...[more]

Similar Datasets

2012-09-05 | E-GEOD-27688 | biostudies-arrayexpress
2008-12-01 | E-GEOD-9820 | biostudies-arrayexpress
2015-10-01 | GSE65013 | GEO
2024-04-08 | E-MTAB-13770 | biostudies-arrayexpress
2015-10-01 | GSE49292 | GEO
2015-08-07 | E-GEOD-59973 | biostudies-arrayexpress
2011-03-15 | GSE20347 | GEO
2023-09-09 | GSE213565 | GEO
2024-09-23 | PXD052250 | Pride
2023-03-11 | PXD038674 | Pride